What is Umeclidinium?

Category: Prescription Drugs

Most popular types: Incruse Ellipta

false

Umeclidinium is a long-term, once-daily, maintenance treatment for patients with chronic obstructive pulmonary disease, chronic bronchitis, and/or emphysema.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 0
None 4

Commonly reported side effects and conditions associated with Umeclidinium

Side effect Patients
Breathing difficulty 1
Chronic constipation 1

Dosages

Based on patients currently taking Umeclidinium

Dosage Patients
62.5 mcg daily 8

Why patients stopped taking Umeclidinium

Multiple reasons could be selected

Reason Patients
Doctor's advice 1
See 1 patient who's stopped taking Umeclidinium

Duration

Currently taking Umeclidinium

Duration Patients
1 - 6 months 2
1 - 2 years 2
2 - 5 years 4

Stopped taking Umeclidinium

Duration Patients
Less than 1 month 1
Adherence
Adherence Evaluations
Always 2
Usually 3
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 2
$50-99 0
$25-49 0
< $25 1
Not specified 2

What people switch to and from

Patients started taking Umeclidinium after stopping:

Treatment Patients
Tiotropium inhaler (Spiriva HandiHaler) 2
Aclidinium Bromide (Tudorza Pressair) 1
Budesonide-Formoterol (Symbicort) 1
Fluticasone-Salmeterol (Advair Diskus) 1
Ipratropium (Ipratropium Inhalant) 1

Show all 6 treatments patients report switching from

Patients stopped taking Umeclidinium and switched to:

Treatment Patients
Aclidinium Bromide (Tudorza Pressair) 1
Amoxicillin (Amoxil) 1
Budesonide-Formoterol (Symbicort) 1
Last updated:
There are no evaluations for Umeclidinium.